Goldman Sachs cut its S&P 500 target and raised its recession forecast. The bank now sees a 35% chance of a recession in the next 12 months. Goldman Sachs is offering up to $160,000 for an ...

Austin-based IntraBio is making headlines in the bio-pharmaceutical world, not just for its recent headquarters relocation ...

15, 2024 — Researchers have identified a potential treatment for Sandhoff and Tay-Sachs diseases -- two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells ...

Goldman Sachs on Tuesday bought shares of auto components major Samvardhana Motherson International for Rs 87 crore through an open market transaction. American multinational Goldman Sachs through its ...

New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

One of the most popular music festivals in small-town Illinois is coming to an end after a 10-year run. SamJam’s Finale is ...

Goldman Sachs is catching fresh heat over massive bonuses it has pledged to CEO David Solomon and his No. 2 executive John Waldron — with powerful shareholder voting advisors slamming the payout ...

The issue of rare diseases is one Anderson often champions. His son, Andrew, suffered from Tay-Sachs disease, an ultrarare fatal genetic disorder with only 16 cases annually nationwide.